Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug

Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.

from NDTV Profit - Latest https://ift.tt/2AV8SU9